Article
A new corrector rescues F508del-CFTR folding through stabilization of the TMD1-NBD1 linker
2025-03-11
Abstract excerpt
<h4>ABSTRACT</h4> While Trikafta has turned many CF patients into people that lead relatively healthy lives, additional modulators are still needed. We developed an acylsulfonamide-type C2 corrector X307810 that is potent and shows a distinctive mode of action in rescuing F508del-CFTR from degradation at the endoplasmic reticulum. We tracked the de-novo folding and assembly of each CFTR domain with a radio-active...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dbe10d01-db61-5a5f-9118-7ea6b8a07bdb
- DOI
- 10.1101/2025.03.10.640553
